These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10793114)

  • 1. Unexpected right phrenic nerve injury during 5-fluorouracil continuous infusion plus cisplatin and vinorelbine in breast cancer patients.
    Munzone E; Nolé F; Orlando L; Mandalá M; Biffi R; Ciano C; Villa G; Civelli M; Goldhirsch A
    J Natl Cancer Inst; 2000 May; 92(9):755. PubMed ID: 10793114
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
    Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
    Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism in breast cancer patients during chemotherapy with vinorelbine, cisplatin, 5-fluorouracil as continuous infusion (ViFuP regimen): is prophylaxis required?
    Orlando L; Colleoni M; Nolè F; Biffi R; Rocca A; Curigliano G; Ferretti G; Peruzzotti G; de Braud F; Masci G; Goldhirsch A
    Ann Oncol; 2000 Jan; 11(1):117-8. PubMed ID: 10690401
    [No Abstract]   [Full Text] [Related]  

  • 4. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients.
    Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L
    Eur J Cancer; 2005 Jan; 41(2):249-55. PubMed ID: 15661550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinorelbine and infusional 5-fluorouracil in anthracycline and taxane pre-treated metastatic breast cancer.
    Stuart NS; McIllmurray MB; Bishop JL; Johnston SR; Price CG; O'Reilly SM; Joffe JK; Neave F; Whipp EC
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):152-6. PubMed ID: 18083354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
    Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
    Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines.
    Berruti A; Sperone P; Bottini A; Gorzegno G; Lorusso V; Brunelli A; Botta M; Tampellini M; Donadio M; Mancarella S; De Lena M; Alquati P; Dogliotti L
    J Clin Oncol; 2000 Oct; 18(19):3370-7. PubMed ID: 11013277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
    Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
    Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
    Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma.
    Segura A; Pastor M; Santaballa A; Yuste A; López P; Aparicio J
    Oncologist; 2000; 5(2):177-8. PubMed ID: 10794811
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe mucositis after chemotherapy with vinorelbine, 5-fluorouracil, leucovorin and cisplatin.
    Monnet I; Chariot P; Azli N; Ruffié P; Voisin S; Saltiel JC; de Cremoux H; Cvitkovic E
    Eur J Cancer; 1991; 27(12):1716-7. PubMed ID: 1664225
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
    Orecchia R; Jereczek-Fossa BA; Catalano G; Chiesa F; De Pas T; Masci G; Krengli M; Vavassori A; De Paoli F; Robertson C; Marrocco E; De Braud F
    Oncology; 2002; 63(2):115-23. PubMed ID: 12239445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptance of external infusion pumps in patients with advanced breast cancer receiving continuous infusion fluorouracil.
    Lombardi D; Di Lauro V; Piani B; Scuderi C; Spazzapan S; Magri MD; Crivellari D; Annunziata MA; De Cicco M; Veronesi A
    Tumori; 2003; 89(5):488-91. PubMed ID: 14870769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: significance of the time between initiation of adjuvant therapy and of therapy for metastatic breast cancer.
    Isik B; Altundag K
    Ann Oncol; 2004 Jan; 15(1):175; author reply 175. PubMed ID: 14679141
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cisplatin and vinorelbine therapy of previously treated advanced breast cancer (preliminary studies)].
    Szatkowska L; Mazurkiewicz M; Brzozowska A
    Pol Merkur Lekarski; 2001 Mar; 10(57):148-9. PubMed ID: 11398513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer.
    Fraschini G; Holmes FA; Buzdar AU; Hug V; Hortobagyi GN
    Am J Clin Oncol; 1988 Aug; 11(4):448-50. PubMed ID: 3407623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.